-

Global Female Technology Market (2019 to 2030) - Featuring Bloomlife, CORA & Flo Health Among Others - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global Female Technology (Femtech) Market: Analysis and Forecast, 2019-2030" report has been added to ResearchAndMarkets.com's offering.

According to this report the global Femtech market generated a revenue of $820.6 million in 2019 and is estimated to grow over $3.04 billion by the end of 2030.

The market is projected to grow at a CAGR of 12.65%, during the forecast period. There are multiple factors that drive the market such as increasing representation of women in the technological community, raising awareness of women's health, growing prevalence of infectious diseases among females in low to middle-income countries, and a surge in funding activities, among others.

Despite having huge potential, the Femtech industry is still immensely underfunded accounting for only 1.4% aggregated capital that flows into healthcare. Also, a large number of healthcare venture capitalists are yet to invest in this sector. Indeed, the amount of investment received by the Femtech industry is on a rise but at a surprisingly slow pace considering the potential of the market.

However, the signs of future growth are also quite evident. Five years ago, the amount of funding received by this sector had barely reached about $100 million. The Femtech industry witnessed more than $500 million funding (till 2019). The number of women-centric startups have significantly multiplied in recent years. This surge is also primarily attributed to the launch of the fertility tracking app by PayPal co-founder Max Levchin in 2013. The app also witnessed high profile VC funding from agencies such as Andreessen Horowitz and Founders Fund.

Today, a large number of start-ups could be seen in the market offering fertility tracking apps, as well as those focused on egg freezing and fertility treatments, women-centric clinical care, and even subscription-based tampons. Some of the top-tier VCs have also entered this field. For example, Kleiner Perkins, has backed a fertility platform called Progyny with a funding of $49 million, while NEA has backed a sexual wellness start-up called Nuelle offering financial support of $23 million.

Currently, the Femtech industry comprises over 200 start-ups globally, and a significant number of such companies are being led by women. Some of the major areas of women's health that are being catered to with the help of technology are menstruation care, sexual health, fertility, and pregnancy care. Within these areas, companies are either developing new solutions such as Flex Disc, Thinx absorbent period underwear, or the Glow fertility and ovulation tracker or focusing on technology-based platforms using subscription-based model to democratize existing products such as birth control products and period products.

Market Dynamics

Drivers

  • Growing recognition of Women in the Domain of Technology
  • Economic Burden of Women's health is more than $500 Billion
  • Explosion of wearable devices and increasing smartphone penetration among women

Challenges

  • Lack of women decision makers
  • Societal taboos surrounding women's health issues
  • Absence of awareness among women in rural areas
  • Lack of scientific studies to back industrial claims

Opportunities

  • Investment in product development for maternal, pre- and neo-natal care
  • Investment in sub-Saharan Africa
  • Product development for menopause management

Key Questions Answered:

  1. How has the market evolved in the last five years, and what are the awaited technological advancements in the field of Femtech?
  2. What are the major market drivers, challenges, and opportunities in the global Femtech market?
  3. What are the underlying structures resulting in the emerging trends within the Femtech industry?
  4. What was the market value of the leading segments of the global Femtech market in 2019?
  5. What are the influencing factors that may affect the market positioning of the key players?
  6. How is the industry expected to evolve during the forecast period 2019-2030?
  7. What are the key developmental strategies which are implemented by the key players to sustain in the competitive market?
  8. What are the key business models employed by the femtech companies to standout in the evolving market?
  9. What is the growth potential of Femtech in each region, including North America, Europe, Asia-Pacific, and Rest-of-the-World?
  10. What are the key regulatory implications in developed and developing regions for Femtech?
  11. What were the funding trends for the Femtech companies in the last three years and how would the funding scenario change during the forecast period?

Companies Mentioned

  • ALYK, Inc.
  • Aytu BioScience, Inc.
  • Biowink GmbH
  • Bloomlife
  • CORA
  • Flo Health, Inc.
  • Glow, Inc.
  • Inne
  • Kasha
  • NaturalCycles Nordic AB
  • Ovia Health
  • Plackal Tech
  • Sustain Natural
  • The Flex Company
  • Thinx, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/9oa79u

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

1 Day Clinical Trial Agreements Training Course: Key Legal, Regulatory and IP (Intellectual Property) Considerations for the EU (European Union) and UK Markets (Mar 18, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Clinical Trial Agreements: Key Legal, Regulatory and IP (Intellectual Property) Considerations for the EU (European Union) and UK Markets Training Course (Mar 18, 2026)" training has been added to ResearchAndMarkets.com's offering. The life sciences sector is heavily regulated and CTAs are some of the most important agreements for companies operating in this sector. Having appropriate CTAs in place is therefore essential for managing relationships between the diffe...

Navigating EU (European Union) and FDA (Food and Drug Administration) Regulations for Drug/Device and Device/Drug Combination Products Training Course (Mar 2nd - Mar 3rd, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Navigating EU (European Union) and FDA (Food and Drug Administration) Regulations for Drug/Device and Device/Drug Combination Products Training Course (Mar 2nd - Mar 3rd, 2026)" training has been added to ResearchAndMarkets.com's offering. Understand the regulatory frameworks governing drug/device and device/drug combinations in the European Union and the USA. The demarcation between medicinal products and devices is becoming ever more important and, with the conve...

Wedding Rings Market Trends, Shares and Growth Prospects 2025-2030 - Cultural and Social Trends Around Minimalism and Modern Design Drive Adoption of Non-Traditional Styles - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Wedding Rings - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Wedding Rings was valued at US$56.7 Billion in 2024 and is projected to reach US$80.7 Billion by 2030, growing at a CAGR of 6.1% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The wedding ring market is expanding due to a combin...
Back to Newsroom